Granulomatous inflammation after Hylan G-F 20 viscosupplementation of the knee - A report of six cases

被引:106
作者
Chen, AL [1 ]
Desai, P [1 ]
Adler, EM [1 ]
Di Cesare, PE [1 ]
机构
[1] NYU, Hosp Joint Dis, Dept Orthopaed Surg, New York, NY 10003 USA
关键词
D O I
10.2106/00004623-200207000-00008
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: Recently, intra-articular viscosupplementation with hyaluronate-derived products has gained popularity as a palliative modality for the treatment of osteoarthritis of the knee. Mild pain or swelling at the site of injection may occur in up to 20% of patients, although severe local inflammation, warmth, and joint effusion are rare. We present a series of six cases in which granulomatous inflammation of the synovium was observed after hyaluronate viscosupplementation of the knee. Methods: Six knees (five patients) treated with intra-articular Hylan G-F 20 viscosupplementation underwent a surgical procedure because of persistent symptoms. Routine histopathological evaluation, supplemented by alcian-blue staining and hyaluronidase digestion, was performed in each case. Results: Chronically inflamed synovium with areas of histiocytic and foreign-body giant-cell reaction was observed surrounding acellular, amorphous material. The material stained with alcian blue, a stain for hyaluronate, which disappeared after hyaluronidase digestion. Conclusions: We believe that the injected hyaluronate (Hylan G-F 20) may have been responsible for the synovitis in our patients and thus may be a pathological cause of recalcitrant symptoms after such injection. It is not known whether the responsible pathological agent was the hyaluronate derivative, a contaminant of the purification process, or a component of the carrier substance. Importantly, it appears that the findings in these patients most likely represent a previously unreported pathological response to a viscosupplementation product. This report should raise clinical awareness about this potential complication.
引用
收藏
页码:1142 / 1147
页数:6
相关论文
共 35 条
[1]
Adams M, 1999, JCR-J CLIN RHEUMATOL, V5, pS18
[2]
The role of viscosupplenentation with hylan G-F 20 (Synvisc(R)) in the treatment of osteoarthritis of the knee: A Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone [J].
Adams, ME ;
Atkinson, MH ;
Lussier, AJ ;
Schulz, JI ;
Siminovitch, KA ;
Wade, JP ;
Zummer, M .
OSTEOARTHRITIS AND CARTILAGE, 1995, 3 (04) :213-225
[3]
A risk-benefit assessment of injections of hyaluronan and its derivatives in the treatment of osteoarthritis of the knee [J].
Adams, ME ;
Lussier, AJ ;
Peyron, JG .
DRUG SAFETY, 2000, 23 (02) :115-130
[4]
ARMSTRONG S, 1994, J RHEUMATOL, V21, P680
[5]
BALAZS EA, 1993, J RHEUMATOL, V20, P3
[6]
The effects of the concentration of high-density polyethylene particles on the bone-implant interface [J].
Brooks, RA ;
Sharpe, JR ;
Wimhurst, JA ;
Myer, BJ ;
Dawes, EN ;
Rushton, N .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2000, 82B (04) :595-600
[7]
Carrabba M., 1995, European Journal of Rheumatology and Inflammation, V15, P25
[8]
INTRAARTICULAR INJECTIONS OF HYALURONAN IN PATIENTS WITH CARTILAGE ABNORMALITIES AND KNEE PAIN - A ONE-YEAR DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY [J].
DAHLBERG, L ;
LOHMANDER, LS ;
RYD, L .
ARTHRITIS AND RHEUMATISM, 1994, 37 (04) :521-528
[9]
Dougados M, 1993, Osteoarthritis Cartilage, V1, P97, DOI 10.1016/S1063-4584(05)80024-X
[10]
Histomorphological reaction of bone to different concentrations of phagocytosable particles of high-density polyethylene and Ti-6Al-4V alloy in vivo [J].
Goodman, SB ;
Davidson, JA ;
Song, Y ;
Martial, N ;
Fornasier, VL .
BIOMATERIALS, 1996, 17 (20) :1943-1947